Table 3 Provision of defined daily doses of DAA therapy and estimated number of treated patients
From: Eliminating viral hepatitis C in Belgium: the micro-elimination approach
| Â | 2015 | 2016 | Total | |||
|---|---|---|---|---|---|---|
DDD (n) | Total (n) | DDD (n) | Total (n) | DDD (n) | Total (n) | |
SOF | 107,075 | 637–1275 | 37,075 | 221–441 | 144,150 | 858–1716 |
SOF/LDV | 1036 | 6–12 | 21,172 | 126–252 | 22,208 | 132–264 |
OBV/PTV/r | 8988 | 54–107 | 19,844 | 118–236 | 28,832 | 172–343 |
Total | 117,099 | 697–1394 | 78,091 | 465–929 | 195,190 | 1162-2323 |